The Cluster Meeting of Gala Technology 2023 (Galatech-2023) which was held in Shinagawa Prince Hotel on May 08-10, achieved a consummation. This scientific cluster gathering consisted of three parallel conferences together, which are The 19th Annual Congress of International Drug Discovery Science and Technology, The 10th Annual International Symposium of Drug Delivery Systems and Global Summit of Cancer Frontier. Our conference was hosted by BIT Group Global Ltd., supported by International Transmembrane Transporter Society, International Society of Digital Medicine, The Asian Society of Natural Products, UK Pharmacogenetics and Stratified Medicine Network, The Czech Pharmaceutical Society and The National Hospital Pharmacists Association of Romanian. This annual conference brought together 200 specialists from 40 countries and areas.
On-site Registration Moment
The first part of Opening Ceremony and Keynote Forum took place on Monday’s morning, Dr. Jin-ichi Inokuchi, Professor of Osaka University, Japan; Dr. Hans Leuenberger, Former Executive Vice President of the Swiss Academy of Engineering Sciences; Prof. Emeritus in Pharm. Technology (University of Basel) at the University of Florida, USA; Dr. Arne Staby, Scientific VP, Novo Nordisk A/S, Denmark; Dr. Neda Zarrin-Khameh, Professor, Baylor College of Medicine, USA; Dr. Methal Albarghouthi, Senior Director, AstraZeneca, USA gave brilliant plenary speeches.
OPlenary Forum
The unique program of Galatech2023 comprised 18 parallel sessions. Hot topics and new ideas on Drug Discovery, drug delivery system and Oncology were hotly discussed and exchanged by presenters and visitors in the three-day’s diversified program.
Parallel Sessions
In welcome banquet, all guests appreciated and joined in the brilliant Japanese traditional performances, also expressed sincerely congratulation to successful Galatech-2023. Depending on the warmly support and good suggestions from all of the participants, we are quite confident in organizing Galatech-2024 which would be better and more successful. All of us are looking forward to meeting you again in 2024.
Welcome Banquet
 |
Dr. H. Michael Shepard, President & CEO, Enosi Life Sciences, USA |
 |
Dr. Tom Blundell, Professor, University of Cambridge, UK |
 |
Dr. Ulo Langel, Professor, Stockholm University, Sweden |
 |
Dr. Mats Larsson, Professor, Department of Physics, Stockholm University, Sweden |
 |
Dr. Maria Koufali, Managing Director, Research and Innovation, Nottingham University Hospitals NHS Trust, UK |
 |
Dr. Ferenc Hudecz, Professor, Department of Organic Chemistry, Eötvös L. University, Hungary |
 |
Dr. Sergey Suchkov, Professor, A.I.Evdokimov Moscow State University of Medicine & Dentistry, Russia |
 |
Dr. Jian Yang, Senior Director, Digital Heath, Eli Lilly and Company, USA |
 |
Dr. Yehuda Shoenfeld, Professor, Sheba Medical Center, Tel-Aviv University, Israel |
 |
Dr. Arne Staby, Scientific VP, CMC Project Management, Biologics, Novo Nordisk A/S, Denmark |
 |
Dr. Michael Markert, Vice President and Global Head of CardioMetabolic Diseases Research, Boehringer Ingelheim, Germany |
 |
Dr. Chuang Kee Ong, Associate Director, Centre of Genomics Research, AstraZeneca UK Limited, UK |
 |
Dr. Ved Srivastava, Vice President of Peptide Chemistry, Intarcia Therapeutics, USA |
 |
Dr. Sylvie Pucheu, Founder and CSO, CILcare, France |
 |
Dr. Andreas Seidl, Chief Operating Officer, Leukocare AG, Germany |
 |
Dr. Wilfried Dathe, External Consultant and Head of Medical Research, Heck Bio-Pharma GmbH, Germany |
 |
Dr. Tomoko Mineno, Professor, Takasaki University of Health and Welfare, Japan |
 |
Dr. Richard Denk, Senior Consultant, Aseptic Processing & Containment, SKAN AG, Switzerland |
 |
Dr. Klaus Groschner, Professor, Chair of Biophysics, Medical University of Graz, Austria |
 |
Dr. Yiqun Li, Head of IT Lilly Biotechnology Center, Eli Lilly and Company, USA |
 |
Dr. Joerg Grosse-Onnebrink, Head, University Children’s Hospital Münster, Germany |
 |
Dr. Steve Gardner, CEO, PrecisionLife Ltd, UK |
 |
Dr. Zhenghong Qin, Professor, Soochow University School of Pharmaceutical Science, China |
 |
Dr. Monika Tandon, Senior Vice President & Head, Glenmark Pharmaceuticals, India |
IDDST-2023 provides an ideal platform to showcase your novel technologies and products. It is developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits.
Why Reserve a Booth at IDDST-2023
• To Meet Face-to-Face with the International Movers and Shakers
• To Meet with Key Decision Marker
• To Explore Business Opportunities
• To Spotlight Advanced Technologies and Their Scientific and Commercial Applications
• To Take Advantage of the Conference's Captive Audience and Networking Opportunities within the Exhibition
Hall
  |
Exhibition Date: |
 |
 |
 |
 |
 |
 |
 |
 |
International Transmembrane Transporter Society
International Society of Digital Medicine
The Asian Society of Natural Products
UK Pharmacogenetics and Stratified Medicine Network
The Czech Pharmaceutical Society
The National Hospital Pharmacists Association of Romanian
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
© 2003-2023 All rights reserved by BITeomics |